HHV8 ORF50 Polyclonal Antibody, FITC Conjugated
Referência bs-0860R-FITC
Tamanho : 100ul
Marca : Bioss
Contactar o distribuidor local :
Telefone : +1 850 650 7790
HHV8 ORF50 Polyclonal Antibody, FITC Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bs-0860R-FITC |
| Product Name | HHV8 ORF50 Polyclonal Antibody, FITC Conjugated |
| Applications | WB |
| Reactivity | Virus |
| Specifications | |
| Conjugation | FITC |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from C-terminus of HHV8 ORF50 strain GK18 |
| Immunogen Range | 601-691/691 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 4961526 |
| Swiss Prot | F5HCV3 |
| Synonyms | HHV8 ORF50; HHV 8; Human Herpes Virus 8; Human herpesvirus 8; Kaposi's sarcoma associated herpes virus; Kaposi's sarcoma associated herpesvirus; KSHV; replication and transcription activator; RTA |
| Background | HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma. |
| Application Dilution | |
| WB | 1:500-1000 |